Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat

Weibo Luo(Southwestern Medical Center), Xu Li(Southern Medical University)
PLoS ONE
March 30, 2012
Cited by 30


Related Papers